Samarth Kulkarni
Chief Executive Officer, Director · CRISPR Therapeutics AG
- 2024
- Oct 28, 2026
- 22
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Samarth Kulkarni files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Raju Prasad - $5.10M in CRSP purchases and sales in the last 12 months
- James R. Kasinger - $1.37M in CRSP purchases and sales in the last 12 months
- Simeon George - $720K in CRSP purchases and sales in the last 12 months
- Naimish Patel - $412K in CRSP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Samarth Kulkarni?
Samarth Kulkarni is a corporate insider, tracked as Chief Executive Officer, Director of CRISPR Therapeutics AG (CRSP). InsiderAlpha holds 22 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Samarth Kulkarni submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Samarth Kulkarni been buying or selling stock?
Recorded transactions: 0 open-market purchases and 16 open-market sales ($16.79M) across all tracked filings.
